News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA) Halts Vial's Consulting Role Amid Probe of Cahuzac



4/26/2013 8:39:54 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Sanofi (SAN) said a consultant to Chief Executive Officer Chris Viehbacher is no longer advising the company after authorities searched his office at the drugmaker as part of a tax probe of a former French minister. Investigators probing former Budget Minister Jerome Cahuzac are looking into his dealings with Daniel Vial, a lobbyist and consultant to the pharmaceutical industry, the Le Parisien newspaper said today. Authorities are looking into whether an offshore bank account held by Cahuzac contained money he received from drug companies, the newspaper said. “Under a mutual agreement, the consulting mission of Mr. Vial was suspended, so that he can dedicate himself to his matters,” Jean-Marc Podvin, a spokesman for Paris-based Sanofi, said in an e-mailed statement to Bloomberg News today.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES